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A B S T R A C T
A 60-year-old Japanese woman presented with subacute progressive muscle pain and weakness in her
proximal extremities. She was diagnosed with influenza A (H3N2) infection a week before the onset of
muscle pain. At the time of admission, she exhibited weakness in the proximal muscles of the upper and
lower limbs, elevated serum liver enzymes and creatinine kinase, and myoglobinuria. She did not
manifest renal failure and cardiac abnormalities, indicating myocarditis. Electromyography revealed
myogenic changes, and magnetic resonance imaging of the upper limb showed abnormal signal
intensities in the muscles, suggestive of myopathy. Muscle biopsy of the biceps revealed numerous
necrotic regeneration fibers and mild inflammatory cell infiltration, suggesting immune-mediated
necrotizing myopathy (IMNM). Necrotized muscle cells were positive for human influenza A (H3N2).
Autoantibody analysis showed the presence of antibodies against the signal recognition particle (SRP),
and the patient was diagnosed with anti-SRP-associated IMNM. She was resistant to intravenous
methylprednisolone pulse therapy but recovered after administration of oral systemic corticosteroids
and immunoglobulins. We speculate that the influenza A (H3N2) infection might have triggered her
IMNM. Thus, IMNM should be considered as a differential diagnosis in patients with proximal muscle
weakness that persists after viral infections.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
Case presentation
A 60-year-old Japanese woman visited the local clinic 23 days
before being admitted to the Nagasaki University Hospital with a
sore throat and fever (39 C) that lasted for 2 days. She had been
taking statins for 6 years to treat her dyslipidemia. She was
diagnosed with influenza A infection by immunochromatographic
testing and was prescribed oseltamivir for 5 days. Her fever
reduced after a day, although her fatigue persisted throughout the
course of medication. Seven days before admission, she noticed
muscle pain and edema in her proximal extremities along with
shortness of breath. Muscle symptoms worsened, and she was
Abbreviations: CK, creatine kinase; SRP, signal recognition particle; IMNMs,
immune-mediated necrotizing myopathies; HMGCR, anti-3 hydroxy-3 methylglu-
tarylcoenzyme A reductase.
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The physician detected symmetrical proximal muscle weakness in
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nd was referred to the Nagasaki University Hospital on the same
ay.
She was alert and had the following vitals on admission: body
emperature, 36.7 C; blood pressure, 135/87 mm Hg; pulse rate,
01 beats/min; respiratory rate, 18 breaths/min; and oxygen
aturation, 98% in room air. She had no family history of muscular
iseases. Manual muscle testing showed a score of 3/3, 4/4, 4/4, 3/
, and 4/4 (right/left) for the shoulder and arm, elbow, forearm, hip,
nd knee muscles, respectively. She had pain in her shoulders and
highs on motion. Pretibial pitting edema was also noticed. The
ndings of chest and abdominal examinations were unremarkable.
eurological examination confirmed that her cranial and periph-
ral nerves were normal. She did not have a rash or erythema.
upplementary Table 1 shows the data from her laboratory tests.
er blood cell counts were normal, and biochemistry tests showed
levated levels of liver enzymes [(aspartate transaminase, 358 U/L;
lanine transaminase, 395 U/L; lactate dehydrogenase, 1,367 U/L
normal, 124–222 U/L)]. Serum CK was elevated at 8,429 U/L
normal, 41–153 U/L) with CK-MB at 469 U/L (normal, 0–15 U/L).
rine myoglobin level was 160 ng/mL (normal, <10 ng/mL).
osuvastatin was discontinued after admission as statin-induced
yopathy was a possible differential diagnosis. Elevated levels of
-terminal-pro hormone BNP (107.0 pg/mL; normal, <55 pg/mL)
nd troponin T (1,520 ng/mL; normal, <0.014 ng/mL) suggested the
resence of myocarditis. However, electrocardiograms, transtho-
acic echocardiography, and gallium-67 myocardial scintigraphy
evealed no abnormal findings. The nerve conduction study
erformed by a neurologist revealed normal peripheral nerves.
Electromyography revealed myogenic changes in her biceps and
triceps. Serum hemagglutination inhibition assay detected anti-
bodies against influenza A (H3N2) at 1:160 titer, whereas that for
H1N1pdm09 was negative (<1:10), confirming influenza A (H3N2)
viral infection.
Subsequently, she was administered intravenous saline (1,000
mL/day) and oral furosemide (20 mg). However, the levels of
muscular enzymes in her serum remained high, and she had
progressive muscular symptoms that made it difficult for her to get
up without help. Magnetic resonance imaging of the left upper
limb revealed areas of high signal intensity in the shoulder and
upper arm muscles on day 14; the findings were nonspecific, but
indicative of myopathy (Supplementary Figure S1). Muscle biopsy
of the left biceps brachii showed necrotizing myopathy with
numerous necrotic regeneration fibers and mild inflammatory cell
infiltration on day 16 (Figure 1A), suggesting immune-mediated
necrotizing myopathy (IMNM). Immunohistochemistry of fresh-
frozen biopsy specimens revealed influenza A (H3N2)-positive
necrotizing muscle cells (Figure 1B). Commercial line immunoas-
say using serum on day 13 was positive for the anti-SRP antibody
against multiple myopathy-related autoantibodies (Supplementa-
ry Table S2). Antinuclear antibody test by immunofluorescence
showed cytoplasmic staining, consistent with the pattern by anti-
SRP antibodies (Figure 1C). Additionally, radioimmunoprecipita-
tion using 35S-methionine-labeled human cells clearly confirmed
the typical patterns of anti-SRP antibody components (Figure 1D).
These tests were confirmed using serum on day 65. Thus, she was
diagnosed with anti-SRP antibody-positive IMNM following the
influenza A (H3N2) infection. She underwent three courses ofigure 1. A. Hematoxylin-eosin staining of the muscle biopsy tissue. Necrotic regeneration fibers (arrows) and mild inflammatory cell infiltration were observed. Scalebar,
00 mm; Magnification, 40. B. Immunostaining of muscle biopsy tissue using anti-human influenza A (H3N2) monoclonal antibody (Clone F49, code No. M146, Takara Bio
c.). Scalebar, 100 mm; Magnification, 40. The lung tissue from an autopsy of influenza A (H3N2) served as the positive control (Takahashi et al., 2000) and confirmed that
ype II lung epithelial cells were stained with the anti-influenza A (H3N2) antibody. A tissue microarray was used as a negative control. The muscle biopsy tissue was negative
r mouse IgG isotype control. C. Antinuclear antibody test by immunofluorescence was positive in a cytoplasmic pattern. D. Immunoprecipitated anti-SRP reference serum,
atient serum, and normal human serum (NHS) were fractionated by 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Components of SRP
SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72) have been indicated.
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exhibited dysphagia, and her muscular enzyme levels remained
high. Immunoglobulins (400 mg/kg) were administered for five
days from day 40 to treat the steroid-resistant myopathy, and oral
corticosteroids (40 mg/day) were initiated on day 44. Her muscle
strength gradually improved and her muscle enzyme levels
reduced (Supplementary Figure S2). She could walk using a walker
on day 58, following which she was transferred to a rehabilitation
hospital on day 67 and was able to walk on her own on day 72.
Discussion
Influenza virus infections typically induce pain in the joints
and muscles along with respiratory symptoms. Myositis was first
described in 1957 as a complication of infection by the influenza
virus (Lundberg, 1957). It is commonly found in children
recovering from acute illness (5.5% and 33.9% infected with
influenza A and B, respectively) (Hu et al., 2004). In adults, muscle
symptoms are less frequent, although myositis was detected in
13.3% in the elderly during the influenza A (H3N2) epidemic
(Yoshino et al., 2000). Half of the adult cases of influenza-
associated myositis are females over the age of 60. The majority of
these patients were infected with influenza A, among which 37%
were positive for influenza A (H3N2) (Sellers et al., 2017).
Myopathy typically begins within one week of the onset of
respiratory symptoms (Sellers et al., 2017). However, the
pathogenesis of influenza-associated myositis is unclear. The
influenza virus has been isolated from muscle tissues, suggesting
that direct viral invasion of muscle fibers accounts for some cases
of myositis (Gamboa et al., 1979; Kessler et al., 1980). Symptoms
typically resolve within a week. However, fatal cases with
rhabdomyolysis and renal failure have also been reported (Sellers
et al., 2017).
IMNMs are a class of acquired autoimmune muscle disorders
caused by various etiologies, including a subset associated with
anti-SRP antibodies, statin-induced myopathy with antibodies
against 3 hydroxy-3 methylglutaryl-coenzyme A reductase
(HMGCR), connective tissue diseases, cancer, and viral infections,
including HIV and hepatitis C (Quinn et al., 2015). IMNMs are
clinically characterized by proximal muscle weakness, high levels
of CK, and myopathic findings using electromyography. Patholog-
ically, IMNMs include muscle fiber necrosis in the absence of
substantial lymphocytic inflammatory infiltration (Stenzel et al.,
2012). Recent studies revealed an increase in the incidence of
IMNMs (Klein et al., 2015) and presence of anti-SRP or anti-HMGCR
antibodies in two-thirds of IMNM patients (Mohammed et al.,
2019). INMNs associated with anti-SRP or anti-HMGCR occur
frequently in women aged between 40 and 60 years (Watanabe
et al., 2016). Anti-SRP IMNM presents with severe muscle
weakness and resistance to immunotherapy compared to anti-
HMGCR positive ones.
In this case, the onset, clinical course, and pathological
findings made it difficult to differentiate among influenza-related
myositis, statin-induced IMNM, and anti-SRP associated IMNM.
Anti-SRP-positive IMNM was reported to show a seasonal trend in
winter (Leff et al., 1991). Prior infection (most commonly viral
infection) or vaccinations (usually influenza vaccination) were
also noted in more than 20% of patients with idiopathic
inflammatory myopathies (Limaye et al., 2017). A woman was
recently reported to have developed anti-SRP-positive IMNM two
differential diagnosis for the present case. However, renal
dysfunction, which is usually correlated with a greater degree
of rhabdomyolysis with severe muscular symptoms (Borgatta
et al., 2012), was not observed in this patient; moreover, she did
not respond to hydration treatment. To the best of our knowledge,
this is the first report of anti-SRP antibody-positive myopathy
following infection with influenza virus. This case report high-
lights the importance of considering IMNM as a differential
diagnosis in patients with progressive proximal myositis that
persists after influenza infection.
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